Medical Weight Loss Treatment for California Residents
Medically Supervised Weight Loss, Delivered Online
OmniRx Health providers are licensed by the Medical Board of California, maintaining full compliance with state telehealth regulations.
Whether you're in Los Angeles, Sacramento, or anywhere across California — our board-certified providers are ready to see you.
Medical Weight Loss Treatment in California
Our board-certified providers prescribe FDA-approved and physician-developed weight loss medications including GLP-1 agonists, customized to your health profile and goals.
No office visits required — 100% online consultations
FDA-approved and physician-developed medications
Personalized dosing protocols adjusted to your response
Ongoing provider support and check-ins throughout treatment
Medications shipped directly to your door from licensed pharmacies
From Silicon Valley innovators to Central Valley farmers, Californians deserve healthcare that fits their lifestyle. OmniRx Health serves the entire Golden State—whether you're navigating LA traffic, working remotely from Lake Tahoe, or managing a vineyard in Napa. Our telehealth platform brings world-class medical expertise directly to you, eliminating the need for lengthy commutes to crowded clinics in a state where time is precious.
Available Treatments in California
Our board-certified providers in California can prescribe and manage the following treatment options
Semaglutide
Semaglutide is a GLP-1 receptor agonist that reduces appetite and slows gastric emptying, helping patients achieve significant, sustained weight loss. Originally developed for type 2 diabetes management, semaglutide has become one of the most clinically effective weight loss medications available.
Tirzepatide
Tirzepatide is a dual GLP-1 and GIP receptor agonist that produces even greater weight loss than semaglutide alone. It addresses appetite, blood sugar regulation, and metabolic rate through two complementary hormonal pathways for superior outcomes.
Tesofensine
Tesofensine is a triple monoamine reuptake inhibitor that suppresses appetite and boosts metabolism through dopamine, norepinephrine, and serotonin pathways. Originally developed as an anti-Parkinson's agent, it showed exceptional weight loss properties in clinical trials.
Retatrutide
Retatrutide (LY3437943) is a 39-amino acid synthetic peptide and triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Currently in Phase 3 clinical trials (TRIUMPH program), it produced 24.2% average weight loss at 48 weeks in Phase 2 data — the highest weight reduction observed in any peptide trial to date. Listed by OmniRx for research-use only (RUO).
Telehealth Regulations in California
State Licensing
OmniRx Health providers are licensed by the Medical Board of California, maintaining full compliance with state telehealth regulations.
Telehealth Law
California's Telehealth Advancement Act ensures broad access to virtual care, with recent legislation permanently expanding telehealth flexibilities established during the pandemic.
Pharmacy Access
We partner with California State Board of Pharmacy licensed pharmacies across LA, San Francisco, San Diego, and statewide for convenient prescription fulfillment.
Insurance Notes
California mandates telehealth parity—insurers must cover virtual visits at the same rate as in-person appointments, including Medi-Cal and commercial plans.
Frequently Asked Questions
Common questions about medical weight loss and telehealth access in California
Explore Related Medical Weight Loss Pages
Direct links to specific treatments, other services, and every state we serve.